The latest announcement is out from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ).
Hansoh Pharmaceutical Group Company Limited has announced a board meeting scheduled for March 21, 2025, to discuss and approve the company’s final results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend and address other business matters, potentially impacting the company’s financial strategies and shareholder returns.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, production, and sale of pharmaceutical products.
YTD Price Performance: 11.34%
Average Trading Volume: 5,864,445
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$114.2B
Find detailed analytics on 3692 stock on TipRanks’ Stock Analysis page.